- Home
- /EGFR gene mutations tested for
EGFR gene mutations tested for
Identifies specific mutations in the EGFR gene from blood or tissue samples.
Why This Biomarker Matters
EGFR mutations guide targeted cancer therapy selection. Knowing your mutation status enables personalized treatment with drugs most likely to work for your specific cancer.
Overview
This test identifies specific mutations in the EGFR (epidermal growth factor receptor) gene from blood or tissue samples. EGFR mutations are commonly found in certain lung cancers and can determine which targeted therapies will be most effective. Different mutations respond differently to specific medications called EGFR inhibitors. Testing for EGFR mutations is crucial for cancer patients to guide treatment selection, predict drug response, and optimize outcomes. This genetic information helps oncologists personalize cancer treatment plans.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
21666-3PrimaryAvailable Lab Tests
Order tests that measure this biomarker